TipRanks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF

Compare Innate Pharma SA (IPHYF) vs. Competitors

27 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma SA
$1.65
$176.00M
-2.65
-17.50%
―
Abivax SA
€99.95
€7.69B
-17.87
18.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
Nanobiotix
€35.74
€1.40B
-23.09
56.60%
1 Buy
0 Hold
0 Sell
Moderate Buy
Transgene
€0.80
€200.92M
-4.27
-36.81%
―
OSE Immunotherapeutics SA
€3.22
€52.70M
-1.29
-69.81%
―
Cellectis SA
€3.10
€96.55M
-2.22
-53.60%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHYF
Innate Pharma SA
1.65
-0.35
-17.50%
FR:ABVX
Abivax SA
84.15
14.15
20.21%
FR:NANO
Nanobiotix
25.40
8.50
50.30%
FR:TNG
Transgene
0.71
-0.42
-36.81%
FR:OSE
OSE Immunotherapeutics SA
2.17
-4.86
-69.10%
FR:ALCLS
Cellectis SA
1.29
-1.59
-55.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts